Bicara Therapeutics, Inc. (BCAX)
14.99
-0.37
(-2.41%)
USD |
NASDAQ |
Feb 09, 16:00
14.99
0.00 (0.00%)
After-Hours: 20:00
Bicara Therapeutics Market Cap : 821.18M for Feb. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Oncotelic Therapeutics, Inc. | 28.77M |
| Pfizer Inc. | 153.80B |
| ACADIA Pharmaceuticals, Inc. | 3.928B |
| Agenus, Inc. | 101.34M |
| Alnylam Pharmaceuticals, Inc. | 42.28B |
Market Cap Related Metrics
| PEG Ratio | -0.0647 |
| Price to Book Value | 2.039 |
| Price | 14.99 |
| Earnings Yield | -14.87% |
| PEGY Ratio | -0.0647 |